The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 3.EBI
Nippon Roche Research Center
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2.EBI
Nippon Roche Research Center
Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 1.EBI
Nippon Roche Research Center
Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase.EBI
Imperial College
Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase.EBI
Imperial College
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis.EBI
University of Dundee
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.EBI
Imperial College
Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.EBI
Imperial College
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.EBI
Imperial College
Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.EBI
Imperial College
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.EBI
University of Dundee
Derivatives of aryl amines containing the cytotoxic 1,4-dioxo-2-butenyl pharmacophore.EBI
Acadia University
 
A chiral recognition element with an unusual size constraint affects the potency and selectivity for peptidomimetic inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferaseEBI
TBA
Fragment Linking Strategies for Structure-Based Drug Design.EBI
Universit£
Novel Thienopyrimidine Inhibitors of EBI
Imperial College London
Fragment-to-Lead Medicinal Chemistry Publications in 2018.EBI
Frontier Medicines
How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using EBI
Johannes Gutenberg-Universit£T Mainz
Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.EBI
G.D. Searle
Design and syntheses of potent and selective dipeptide inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferase.EBI
G.D. Searle And
A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.EBI
University of Dundee
Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.EBI
University of Dundee